These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6181704

  • 41. Passive immunotherapy of cancer in animals and man.
    Rosenberg SA, Terry WD.
    Adv Cancer Res; 1977; 25():323-88. PubMed ID: 326003
    [No Abstract] [Full Text] [Related]

  • 42. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D, Jäger E, Bert F, Knuth A.
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract] [Full Text] [Related]

  • 43. Short review. Prospects for cancer immunochemotherapy.
    Rubens RD.
    Cancer Treat Rev; 1974 Dec; 1(4):305-12. PubMed ID: 4219751
    [No Abstract] [Full Text] [Related]

  • 44. Immunological approaches to the treatment of malignant disease.
    Guillou PJ.
    J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468
    [No Abstract] [Full Text] [Related]

  • 45. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM, Del Prete G, Amedei A.
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [Abstract] [Full Text] [Related]

  • 46. [Immunity against cancer--a critical review of recent progress--].
    Yamamura Y.
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):311-9. PubMed ID: 6192758
    [Abstract] [Full Text] [Related]

  • 47. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M, Shibaguchi H, Imakiire T, Uno K, Shirota K, Higuchi T, Shitama T, Yamada H, Hirose Y, Nagata A, Kuroki M.
    Anticancer Res; 2003 Feb; 23(6a):4377-81. PubMed ID: 14666724
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A, Lochmüller H.
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N, Zoernig I, Jäger D.
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Research on neoplastic antigens].
    De Barbieri A, Tassi GC.
    Boll Ist Sieroter Milan; 1971 Oct; 50(4):243-50. PubMed ID: 5163492
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.